2.74% 1.2597

Harrow Inc (HROW)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HROW? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1195)

615.733.4731

102 WOODMONT BLVD, NASHVILLE, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HROW's Discussions on Twitter

Vergleichen Sie HROW mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HROW	43.87	1.51B	154.15M	-33.58M	-20.74M	-0.56
ZTS	176.59	78.47B	9.15B	2.43B	2.31B	4.92
HLN	9.525	42.84B	14.26B	1.55B	0	0.3327
TAK	13.29	42.13B	30.27B	1.93B	3.45B	0.444
TEVA	17.14	19.19B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.21	15.67B	15.24B	-646.50M	1.88B	1.53

Harrow Inc Stock (HROW) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-09-08	Fortgesetzt	B. Riley Securities	Buy
2021-10-14	Fortgesetzt	B. Riley Securities	Buy
2021-09-24	Eingeleitet	Aegis Capital	Buy
2021-07-02	Eingeleitet	Ladenburg Thalmann	Buy

Harrow Inc Aktie (HROW) Neueste Nachrichten

Finanzdaten der Harrow Inc-Aktie (HROW)

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Vergleichen Sie HROW mit anderen Aktien

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Aktie (HROW) Neueste Nachrichten

Harrow subsidiary wins $34.9 million in trademark case - Investing.com

Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com UK

Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX | HROW Stock News - StockTitan

HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com

HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com

HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com

HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com

HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com

HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com

HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com

First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat

Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat

Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha

Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat

Harrow Announces Participation in Upcoming Investor Conferences - BioSpace

Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey

Harrow to Present at Major Healthcare Conferences, Including Piper Sandler's Annual Event | HROW Stock News - StockTitan

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance

Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy

Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday

Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks

Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Q3 2024 Harrow Inc Earnings Call Transcript - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings: Revenue at $49.3M, Misses Es - GuruFocus.com

Los Angeles Capital Management LLC Sells 38,168 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow: Q3 Earnings Snapshot - New Haven Register

Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN

Harrow stock plunges 20% on weaker-than-expected Q3 earnings (NASDAQ:HROW) - Seeking Alpha

Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

HROWHarrow, Inc. Latest Stock News & Market Updates - StockTitan

Harrow Q3 Revenue Surges 44% to $49.3M as VEVYE Prescriptions Jump 55% | HROW Stock News - StockTitan

Harrow Inc (HROW) Shares Up 6.99% on Nov 13 - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Harrow Partners with GoodRx, Cuts Prices on Key Eye Drug Portfolio | HROW Stock News - StockTitan

Harrow secures Medicare coverage for dry eye treatment VEVYE By Investing.com - Investing.com Canada

Harrow Inc (HROW) Stock Price Down 3.18% on Nov 12 - GuruFocus.com

Earnings Outlook For Harrow - Benzinga

Harrow secures Medicare coverage for dry eye treatment VEVYE - Investing.com India

Harrow Announces Market Access Wins for VEVYE® - Business Wire

Harrow's VEVYE Secures Major Medicare Coverage, Reaching 25M+ Beneficiaries in 2025 | HROW Stock News - StockTitan

Harrow: VEVYE And Its Impact On The DED Market (NASDAQ:HROW) - Seeking Alpha

Equitable Trust Co. Has $2.62 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Woodmont Investment Counsel LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products - Business Wire

Best Momentum Stocks To Buy For November 6th - Barchart

Finanzdaten der Harrow Inc-Aktie (HROW)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HROW